Raymond James Maintains Outperform on Johnson & Johnson, Lowers Price Target to $172
Portfolio Pulse from Benzinga Newsdesk
Raymond James analyst Jayson Bedford has maintained an 'Outperform' rating on Johnson & Johnson (NYSE:JNJ), but lowered the price target from $179 to $172.
October 18, 2023 | 1:31 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Johnson & Johnson's price target has been lowered from $179 to $172 by Raymond James, though the 'Outperform' rating is maintained.
The news is directly about Johnson & Johnson and is likely to impact its stock. While the 'Outperform' rating is maintained, the lowering of the price target might create some uncertainty among investors, potentially affecting the stock's performance in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100